123 related articles for article (PubMed ID: 1830934)
1. Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment.
Nakamura Y; Chida Y; Tomura S
Nephron; 1991; 58(2):201-4. PubMed ID: 1830934
[TBL] [Abstract][Full Text] [Related]
2. Enhanced fibrinolytic activity during the course of hemodialysis.
Nakamura Y; Tomura S; Tachibana K; Chida Y; Marumo F
Clin Nephrol; 1992 Aug; 38(2):90-6. PubMed ID: 1387598
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment.
Tomura S; Nakamura Y; Deguchi F; Ando R; Chida Y; Marumo F
Thromb Res; 1991 Oct; 64(1):81-90. PubMed ID: 1776141
[TBL] [Abstract][Full Text] [Related]
4. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
Tomura S; Nakamura Y; Tachibana K; Deguchi F; Ando R; Chida Y; Marumo F
Blood Purif; 1993; 11(6):370-7. PubMed ID: 8043258
[TBL] [Abstract][Full Text] [Related]
5. The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin.
Ichinose A; Aoki N
Thromb Res; 1986 Mar; 41(6):847-54. PubMed ID: 2939589
[TBL] [Abstract][Full Text] [Related]
6. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayasaki J; Hayakawa M
Clin Lab; 2018 Apr; 64(4):433-442. PubMed ID: 29739066
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
8. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
9. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
10. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
Takeda S; Katoh H; Takaki A; Okamoto K; Ohsato K
Thromb Res; 1990 Jan; 57(2):289-300. PubMed ID: 2156347
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.
Deguchi K; Izumi K; Noguchi M; Yuwasaki E; Suzuki H; Mori Y; Deguchi A; Ohkubo I; Tsuda M; Wada H
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646
[TBL] [Abstract][Full Text] [Related]
12. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis.
Homma S; Masunaga Y; Kurosu M; Inoue M; Sakurai T; Asano Y
Perit Dial Int; 2002; 22(2):178-83. PubMed ID: 11990401
[TBL] [Abstract][Full Text] [Related]
13. Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.
Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayakawa M
Int J Lab Hematol; 2021 Aug; 43(4):813-820. PubMed ID: 33301236
[TBL] [Abstract][Full Text] [Related]
14. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
15. Profile of blood coagulation and fibrinolysis in chronic myeloproliferative disorders.
Takahashi H; Hattori A; Shibata A
Tohoku J Exp Med; 1982 Sep; 138(1):71-80. PubMed ID: 6959382
[TBL] [Abstract][Full Text] [Related]
16. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
Mimuro J; Kimura S; Aoki N
J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
[TBL] [Abstract][Full Text] [Related]
17. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
Oikawa T; Muramatsu Y; Akashi S; Usui N
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
[TBL] [Abstract][Full Text] [Related]
18. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
[TBL] [Abstract][Full Text] [Related]
19. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
[TBL] [Abstract][Full Text] [Related]
20. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
